Sex (exclusively for female) Heredity (history of cervical CA)
PRECIPITATING FACTORS Sexual partner who had multiple sexual partner (HPV exposure) Low economic status Diet and lifestyle Multiple Pregnancies (7 and above delivered)
Somatic Mutation in DNA or Gene
Altered genetic structure and autoimmune response
Activated oncogene or deactivate cell tumor suppressor gene
Formation of clones or uncontrolled proliferation lymphocytes
Malignant transformation of lymphoid stem cells
Acquisition of invasive characteristics
Cervix cells dysplasia after lymphoblastic cell event
Tumor cells engulf lymphocytes
Through sexual intercourse: HPV penetrates squamous columnar epithelial cervix cells
Drug Classification of Drug Mechanism of Action (Indication) Side Effects Nursing Considerations Date and Time Ordered Administered Trade Name: Prilosec
Short-term treatment of active duodenal ulcer; First-line therapy in treatment of heartburn or symptoms of gastroesophageal reflux disease (GERD); Short- term treatment of active benign gastric ulcer; GERD,severeerosiveeso phagitis,poorlyresponsiv esymptomaticGERD;Lon g- termtherapy:Treatmentof pathologichypersecretor yconditions (Zollinger- Ellisonsyndrome,multiple adenomas,systemicmast ocytosis);Eradication of H. pylori With amoxicillin or metronidazole. -CNS: Head ache, dizziness, fatigue. -GI: Diarrhea, abdominal pain, nausea, mild transient increases in liver function tests. -Urogenital: Hematuria, proteinuria. Skin: Rash.
-Lab tests: Monitor urinalysis for hematuria and proteinuria. Periodic liver function tests with prolonged use. -Report any changes in urinary elimination such as pain or discomfort associated with urination, or blood in urine. -Report severe diarrhea; drug may need to be discontinued. -Do not breast feed while taking this drug. 09/24/2014 6:30 am 09/25/2014 6:00pm Drug Classification of Drug Mechanism of Action (Indication) Side Effects Nursing Considerations Date and Time Ordered Administered Trade Name: GODEX DS
Hepatic Protectors, Cholagogues & Cholelitho- lytics Treatment of mitochondrial dysfunction, acute & chronic hepatitis, fatty liver, liver cirrhosis, liver intoxication by drug or chemical substance. A complex ionic salt of L- carnitine and Orotic acid which has a greater advantage, in terms of absorbability and bioavailability Stimulate an efficient function of the Mitochondrial Energy System, restoring normal cell functions and protecting cell membrane integrity. Precursor of nucleic acid and protein synthesis, needed for injured cell regeneration. A potent lipotropic factor Improves normal detoxification in the cells. Hypertension Fever Tachycardia Seizures Abdominal or stomach cramps diarrhea headache in dialysis patients with ESRD nausea or vomiting Incidence less frequent gastritis (abdominal discomfort ; loss of appetite) Most are dose related Monitor patients tolerance during the 1 st week of therapy and after increasing dosage. Caution patient not to share drug with others. May give enteral liquid alone or dissolved in drinks or liquid food. Do not refrigerate solution.
9/26/2014 7:00 am
9/27/2014 8:00 am Trade Name Classification of Drug Mechanism of Action (Indication) Side Effects Nursing Considerations Date and Time Ordered Administered Dulcolax
Bisacodyl
Stimulant Laxative For relief of occasional constipation This product generally produces bowel movement in 15 minutes to 1 hour
Before -Check for the doctors order-Confirm patients identity-Prepare the medicine- Assess patient for abdominal distension, presence of bowel sounds and usual pattern of bowel function.-Assess patients and familys knowledge of drug therapy During -Administer at bedtime for morning results- P.O: taking on an empty stomach will produce more rapid results.-Do not crush or chew enteric coated tablets. Take with full glass of water or juice-Do not administer oral doses within 1 hr of milk or antacid causes gastric irritation-Consider rights of drug administration 9/24/2014 6:30 am
9/25/2014 6:00 pm
After -Advise patient that laxatives should be used only for short-term therapy. Prolonged use may lead to electrolyte imbalance & dependence.-Advise to increase oral fluid intake to1500-2000 ml/day to prevent dehydration-Encouraged pt. to use other forms of bowel regulation-Advise pt. that bisacodyl should not be used when constipation is accompanied by abdominal pain, fever, N/V- Report any signs of unusualities.
Drug Classification of Drug Mechanism of Action (Indication) Side Effects Nursing Considerations Date and Time Ordered Administered Trade Name: Cenolate, Cevita Generic Name: Ascrobic Acid (Vitamin C) vitamin Pregnancy Category: C Water-soluble vitamin essential for synthesis and maintenance of collagen and intercellular ground Hematologic: Acute hemolytic anemia (patients with deficiency of G6PD); sickle cell crisis. CNS: Headache or insomnia (high doses). Urogenital: Urethritis, dysuria, crystaluria, hyperoxaluria, or hyperuricemia (high doses). other: Mild soreness at injection site; dizziness and temporary faintness with rapid IV administration. Patient & Family Education - High doses of vitamin C are not recommended during pregnancy.
9/24/2014 6:30 am
9/25/2014 8:00am -Take large doses of vitamin C in divided amounts because the body uses only what is needed at a particular time and excretes the rest in urine. -Mega doses can interfere with absorption of vitamin B12. - Note: Vitamin C increases the absorption of iron when taken at the same time as iron-rich foods. -Do not breast feed while taking this drug without consulting physician
substance of body tissue cells, blood vessels, cartilage, bones, teeth, skin, and tendons. Unlike most mammals, humans are unable to synthesize ascorbic acid in the body; therefore it must be consumed daily.
Drug Classification of Drug Mechanism of Action (Indication) Side Effects Nursing Considerations Date and Time Ordered Administered Trade Name: Mephyton
Generic Name: Vitamin K (Phytomenadione) fat-soluble vitamins, Anti- fibrinolytic Agents Hypoprothrombinemi a secondary to vitamin K malabsorption, drug therapy, or excessive vitamin A dosage. -An antihemorrhagic actor that promotes hepatic formation of active prothrombin.
dizziness transient hypotension after IV administration rapid and weak pulse diaphoresis flushing erythema pain swelling hematoma at injection site.
IV use: Dilute with 0.9% sodium chloride for injection, D5W, or D5W in 0.9% sodium chloride for injection. Give IV by slow infusion over 2 to 3 hours. Rate shouldnt exceed 1 mg/minute in adults or 3 mg/m2/minute in children. Effects of IV injection are more rapid but shorter-lived than SC or IM injections. Protect parenteral products from light. Wrap infusion container with aluminum foil. For IM administration in adults and older children, administer in upper outer quadrant of buttocks; for infants, administer in the anterolateral aspect of thigh or deltoid region. Anticipate order of weekly addition of 5 to 10 mg of phytonadione to total parenteral nutrition solutions. Monitor PT to determine dosage effectiveness as ordered. If severe bleeding occurs, dont delay other measures, such as fresh frozen plasma or whole blood. Alert: watch for signs of flushing, weakness, tachycardia and hypotension; may progress to shock. Be aware that phytomenadione therapy for hemorrhagic disease in infants causes fewer adverse reactions than do other vitamin K analogues. Failure to respond to vitamin K may indicate coagulation defects.
09/24/2014 6:30 am 9/25/2014 6:00 pm Drug Classification of Drug Mechanism of Action (Indication) Side Effects Nursing Considerations Date and Time Ordered Administered Trade Name: Transamin
Generic Name:
Tranexamic Acid Anti-fibrinolytic, antihemorrhagic -Surgical: General surgical cases but most especially operative procedures on the prostate, uterus, thyroid, lungs, heart, ovaries, adrenals, kidneys, brain, tonsils, lymph nodes and soft tissues. -Obstetrical and gynecological: abortion, post- partum hemorrhage and menometrorrahgia
Severe allergic reactions such as rash, hives, itching, dyspnea, tightness in the chest, swelling of the mouth, face, lips or tongue Calf pain, swelling or tenderness Chest pain Confusion Coughing up blood Decreased urination Severe or persistent headache Severe or persistent body malaise Shortness of breath Slurred speech Slurred speech Vision changes
Nursing Responsibilities Unusual change in bleeding pattern should be immediately reported to the physician. For women who are taking Tranexamic acid to control heavy bleeding, the medication should only be taken during the menstrual period. Tranexamic Acid should be used with extreme caution in CHILDREN younger than 18 years old; safety and effectiveness in these children have not been confirmed. The medication can be taken with or without meals. Swallow Tranexamic Acid whole with plenty of liquids. Do not break, crush, or chew before swallowing. If you miss a dose of Tranexamic Acid, take it when you remember, then take your next dose at least 6 hours later. Do not take 2 doses at once. Inform the client that he/she should inform the physician immediately if severe side effects occur. 9/24/2014 6:30 am